Diabetes and Immunocompromise: Understanding the Link

Diabetes mellitus is not a primary immunodeficiency, but chronic hyperglycemia causes secondary immune dysfunction, increasing infection risk and impairing wound healing.

Mechanisms

  • Neutrophil/Macrophage Impairment: Reduced chemotaxis, phagocytosis, oxidative burst.
  • Cytokine Dysregulation: Altered IL‑1, TNF‑α, IFN‑γ signaling disrupts immune coordination.
  • Glycation Effects: Advanced glycation end‑products (AGEs) impair collagen cross‑linking and leukocyte function.
  • Vascular Complications: Microangiopathy reduces tissue perfusion and leukocyte delivery.

Clinical Consequences

  • Higher incidence of skin/soft‑tissue infections, UTIs, pneumonia, tuberculosis.
  • Delayed wound healing → chronic ulcers, amputations.
  • Type 1 diabetes associates with autoimmune thyroiditis, celiac disease—further immune dysregulation.

Mitigation: Tight glycemic control (HbA1c <7%), routine vaccinations (flu, pneumococcal, hepatitis B, COVID‑19), meticulous foot care, prompt infection treatment, and multidisciplinary management preserve immune competence.

Diabetes - Related Articles